Antibody-based IL-7R targeted therapies

Project Information

IL7RsignaTHER

Grant agreement ID: 862545

DOI

10.3030/862545

Project closed

EC signature date 30 July 2019

Start date 1 January 2020

End date 31 December 2021

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Portugal

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.

Author(s): A. Almeida, J.L. Neto, A. Cachucho, M. Euzébio, X. Meng, R. Kim, M.B. Fernandes, B. Raposo, M.L. Oliveira, D. Ribeiro, R. Fragoso, P.P. Zenatti, T. Soares, M.R. de Matos, J. Ronchi Corrêa, M. Duque, K.G. Roberts, Z. Gu, C. Qu, S. Pyne, N.J. Pyne, V.M. Barreto, I. Bernard-Pierrot, E. Clappier, C.G. Mullighan, A.R. Grosso, J.A. Yunes, J.T. Barata
Published in: Nature Communications, 2021, ISSN 2041-1723
Publisher: Nature Publishing Group
DOI: 10.1038/s41467-021-27197-5